The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Mostafa, Gehan A ^a,b   AL Ayadhi, Laila Y ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Anti ribosomal p protein antibodies; autism; Autoimmunity; Neurokinin a

Indexed keywords

NEUROKININ A; PROTEIN ANTIBODY; RIBOSOME PROTEIN P ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; RIBOSOMAL PROTEIN P0; RIBOSOME PROTEIN;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTISM; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD; BLOOD; IMMUNOLOGY; SAUDI ARABIA;

AUTISTIC DISORDER; AUTOANTIBODIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEUROKININ A; RIBOSOMAL PROTEINS; SAUDI ARABIA;

EID: 83755196664     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-180     Document Type: Article

References (53)

1. Geppetti P, Nassini R, Materazzi S, Benemei S. The concept of neurogenic inflammation. BJU Int 2008, 101(Suppl 3):2-6.
2. Richardson JD, Vasko MR. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 2002, 302(3):839-45. 10.1124/jpet.102.032797, 12183638.
3. Nockher WA, Renz H. Neurotrophins in inflammatory lung diseases: modulators of cell differentiation and neuroimmune interactions. Cytokine Growth Factor Rev 2003, 14:559-78. 10.1016/S1359-6101(03)00071-6, 14563357.
4. Micera A, Lambiase A, Bonini S. The role of neuromediators neuromediators in ocular allergy. Curr Opin Allergy Clin Immunol 2008, 8(5):466-71. 10.1097/ACI.0b013e32830e6b17, 18769203.
5. Maggi CA. The troubled story of tachykinins and neurokinins. Trends Pharmacol Sci 2000, 21:173-175. 10.1016/S0165-6147(00)01463-2, 10785650.
6. Almeida TA, Rojo J, Nieto PM, Pinto FM, Hernandez M, Martin JD, et al. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 2004, 11:2045-81.
7. Ramalho R, Raquel Soares R, Nuno Couto N, Moreira A. Tachykinin receptors antagonism for asthma: a systematic review. BMC Pulm Med 2011, 11:41. 10.1186/1471-2466-11-41, 3163224, 21810226.
8. Ettorre A, D'Andrea P, Mauro S, Porcelloni M, Rossi C, Altamura M, et al. hNK2 receptor antagonists. The use of intramolecular hydrogen bonding to increase solubility and membrane permeability. Bioorg Med Chem Lett 2011, 21(6):1807-1809. 10.1016/j.bmcl.2011.01.074, 21320781.
9. Sigfridsson K, Ahlqvist M, Lindsjö M, Paulsson S. Early development evaluation of AZD2738, a substrate for the NK receptors. Drug Dev Ind Pharm 2011, 37(6):719-726. 10.3109/03639045.2010.538060, 21323487.
10. Sigfridsson K, Ahlqvist M, Carlsson A, Fridström A. Early development evaluation of AZD8081: a substrate for the NK receptors. Drug Dev Ind Pharm 2011, 37(6):702-713. Autoimmunity. 2005; 38(1):85-92, 10.3109/03639045.2010.535823, 21417618.
11. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993, 7(1):97-103. 10.1006/brbi.1993.1010, 7682457.
12. Singh VK, Warren RP, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 1997, 17(1):88-90. 10.1016/S0887-8994(97)00045-3, 9308986.
13. Singh VK, Lin SX, Yang VC. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 1998, 89(1):105-108. 10.1006/clin.1998.4588, 9756729.
14. Singh VK, Rivas WH. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci Lett 2004, 355(1-2):53-56. 10.1016/j.neulet.2003.10.026, 14729233.
15. Mostafa GA, El-Sayed ZA, Abd El Aziz MM, El-Sayed MF. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J Child Neurol 2008, 23:1413-1418. 10.1177/0883073808319321, 19073846.
16. Mostafa GA, Al-Ayadhi LY. Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflammation 2011, 8:39. 10.1186/1742-2094-8-39, 3104945, 21513576.
17. Mostafa GA, Al-Ayadhi LY. A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Neuroinflammation 2011, 8:71. 10.1186/1742-2094-8-71, 3142225, 21696608.
18. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 1999, 14:388-394. 10.1177/088307389901400608, 10385847.
19. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003, 112(5):420-424.
20. Mostafa GA, Kitchener N. Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children. Pediatr Neurol 2009, 40:107-112. 10.1016/j.pediatrneurol.2008.10.017, 19135624.
21. Mostafa GA, Shehab A. The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J Neuroimmunol 2010, 223:115-119. 10.1016/j.jneuroim.2010.03.025, 20452682.
22. Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol 2010, 219:114-118. 10.1016/j.jneuroim.2009.12.003, 20036015.
23. Mostafa GA, Shehab A AL, Fouad NR. Frequency of CD4+CD25high regulatoryT cells in the peripheral blood of Egyptian children with autism. J Child Neurol 2010, 25:328-335. 10.1177/0883073809339393, 19713552.
24. Warren RP, Singh VK, Cole P, Odell JD, Pingree CB, Warren WL, White E. Increased frequency of the null allele at the complement C4b locus in autism. Clin Exp Immunol 1991, 83:438-440. 1535320, 2004485.
25. Odell D, Maciulis A, Cutler A, Warren L, McMahon WM, Coon H, et al. Confirmation of the association of C4B null allele in autism. Human Immunol 2005, 6(2):140-145.
26. Gerli R, Caponi L. Anti-ribosomal P protein antibodies. Autoimmunity 2005, 38(1):85-92. 10.1080/08916930400022699, 15804709.
27. Toubi E, Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 2007, (3):119-125.
28. Veres TZ, Rochlitzer S, Braun A. The role of neuro-immune cross-talk in the regulation of inflammation and remodelling in asthma. Pharmacol Ther 2009, 122(2):203-214. 10.1016/j.pharmthera.2009.02.007, 19292991.
29. Satake H, Kawada T. Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors. Current Drug Targets 2006, 7(8):963-974. 10.2174/138945006778019273, 16918325.
30. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington DC: American Psychiatric Association, 4, American Psychiatric Association.
31. Schopler E, Reichler RJ, Renner BR. The Childhood Autism Rating Scale (CARS), for Diagnostic Screening and Classification in Autism. 1986, New York, NY: Irvington.
32. Zhang Y, Berger A, Milne CD, Paige CJ. Brain Dev. Tachykinins in the immune system. Curr Drug Targets 2006, 7(8):1011-1020. 10.2174/138945006778019363, 16918329.
33. Angelidou A, Francis K, Vasiadi M, Alysandratos KD, Zhang B, Theoharides A, et al. Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation 2010, 7:48. 10.1186/1742-2094-7-48, 2936302, 20731814.
34. Mostafa GA, Reda SM, Abd El-Aziz MM, Ahmed SA. Sputum neurokinin A in Egyptian asthmatic children and adolescents: relation to exacerbation severity. Allergy 2008, (9):1244-1247.
35. Frieri M. Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann Allergy Asthma Immunol 2003, 90(6 Suppl 3):34-40.
36. Qureshi GA, Baig SM, Parvez SH. Variation in cerebrospinal fluid levels of neuropeptide Y, cholecystokinin and substance P in patients with neurological disorders. Neuro Endocrinol Lett 2000, 21(5):409-416.
37. Reinke EK, Johnson MJ, Ling C, Karman J, Lee J, Weinstock JV, et al. Substance P receptor mediated maintenance of chronic inflammation in EAE. J Neuroimmunol 2006, 180(1-2):117-125. 10.1016/j.jneuroim.2006.07.010, 16942803.
38. Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, Hashimoto O, et al. Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study. Brain Dev 2007, 29(8):510-513. 10.1016/j.braindev.2007.01.010, 17376622.
39. Marriott I. The role of tachykinins in central nervous system inflammatory responses. Front Biosci 2004, 9:2153-65. 10.2741/1377, 15353277.
40. Theoharides TC, Kempuraj D, Kourelis T, Manola A. Human mast cells stimulate activated T cells: implications for multiple sclerosis. Ann N Y Acad Sci 2008, 1144:74-82. 10.1196/annals.1418.029, 19076366.
41. Cohly HH, Panja A. Immunological findings in autism. Int Rev Neurobiol 2005, 71:317-341.
42. Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol 2002, 129(1-2):, 168-177.
43. Al-Ayadhi LY, Mostafa GA. Low plasma progranulin levels in children with autism. J Neuroinflammation 2011,
44. Al-Ayadhi LY, Mostafa GA. Increased serum osteopontin levels in autistic children: Relation to the disease severity. Brain Behav Immun 2011, 25(7):1393-1398. 10.1016/j.bbi.2011.04.006, 21521652.
45. Ben-Ami SD, Blank M, Altman A. The clinical importance of anti-ribosomal-P antibodies. Harefuah 2010, 149(12):794-797.
46. Mostafa GA, Ibrahim DH, Shehab AA, Mohammed AK. The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus. J Neuroimmunol 2010, 227(1-2):195-201. 10.1016/j.jneuroim.2010.07.014, 20724007.
47. Katzav A, Solodeev I, Brodsky O, Chapman J, Pick CG, Blank M, Zhang W, Reichlin M, Shoenfeld Y. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007, 56(3):938-948. 10.1002/art.22419, 17328071.
48. Nockher WA, Renz H. Neurotrophins in allergic diseases: From neuronal growth factors to intercellular signaling molecules. J Allergy Clin Immunol 2006, 117:583-589. 10.1016/j.jaci.2005.11.049, 16522457.
49. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004, 201:167-80. 10.1002/jcp.20061, 15334652.
50. Renz H, Kerzel S, Nockhe WA. The role of neurotrophins in bronchial asthma: contribution of the pan-neurotrophin receptor p751. Prog Brain Res 2004, 146:325-333.
51. Herberth G, Daegelmann C, Weber A, Röder S, Giese T, Krämer U, et al. Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children. Clin Exp Allergy 2006, 36(11):1408-1416. 10.1111/j.1365-2222.2006.02576.x, 17083351.
52. Herberth G, Daegelmann C, Weber A, Röder S, Giese T, Krämer U, et al. Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children. Clin Exp Allergy 2006, 36(11):1408-1416. 10.1111/j.1365-2222.2006.02576.x, 17083351.
53. Sekimoto M, Tsuji T, Matsuzaki J, Chamoto K, Koda T, Nemoto K, et al. Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cells. Immunol Lett 2003, 88:221-226. 10.1016/S0165-2478(03)00080-4, 12941481.